[1]
Aggarwal, D., Randhawa, G.K. and Chander, R. 2025. A prospective, randomized, open-label study to compare the efficacy and safety of metformin versus metformin and fluoxetine in patients of type 2 diabetes mellitus with mild depression. International Journal of Basic & Clinical Pharmacology. 14, 5 (Aug. 2025), 716–725. DOI:https://doi.org/10.18203/2319-2003.ijbcp20252567.